Search Results - "Pauly, D.F"

Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling by Deng, M. C., Eisen, H. J., Mehra, M. R., Billingham, M., Marboe, C. C., Berry, G., Kobashigawa, J., Johnson, F. L., Starling, R. C., Murali, S., Pauly, D. F., Baron, H., Wohlgemuth, J. G., Woodward, R. N., Klingler, T. M., Walther, D., Lal, P. G., Rosenberg, S., Hunt, S.

“…Rejection diagnosis by endomyocardial biopsy (EMB) is invasive, expensive and variable. We investigated gene expression profiling of peripheral blood…”
Get full text

465 A Multivariate Analysis of Clinical Parameters That Affect Gene Expression Profile Assessment of Immune Activation by Patterson, B, Springfield, B, Hill, J.A, Aranda, J.M, Schofield, R.S, Szady, A.D, Humphlett, P.K, Pauly, D.F

Get full text

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies by Ware, J.S, Li, J, Mazaika, E, Yasso, C.M, DeSouza, T, Cappola, T.P, Tsai, E.J, Hilfiker-Kleiner, D, Kamiya, C.A, Mazzarotto, F, Cook, S.A, Halder, I, Prasad, S.K, Pisarcik, J, Hanley-Yanez, K, Alharethi, R, Damp, J, Hsich, E, Elkayam, U, Sheppard, R, Kealey, A, Alexis, J, Ramani, G, Safirstein, J, Boehmer, J, Pauly, D.F, Wittstein, I.S, Thohan, V, Zucker, M.J, Liu, P, Gorcsan, J, McNamara, D.M, Seidman, C.E, Seidman, J.G, Arany, Z

“…(N Engl J Med. 2016;374:233–241)It is possible that peripartum cardiomyopathy is influenced by genetic factors, though this remains unclear. Similar to…”
Get full text

477: The daily steroid dose correlates more strongly than the time since heart transplant with a gene expression profile assessment of immune activation by Pauly, D.F, Aranda, J.M, Schofield, R.S, Normann, S.J, Hill, J.A

Get full text

Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial by Eisen, H. J., Kobashigawa, J., Starling, R. C., Pauly, D. F., Kfoury, A., Ross, H., Wang, S.‐S., Cantin, B., Van Bakel, A., Ewald, G., Hirt, S., Lehmkuhl, H., Keogh, A., Rinaldi, M., Potena, L., Zuckermann, A., Dong, G., Cornu‐Artis, C., Lopez, P.

“…In an open‐label, 24‐month trial, 721 de novo heart transplant recipients were randomized to everolimus 1.5 mg or 3.0 mg with reduced‐dose cyclosporine, or…”
Get full text

The ESCAPE Discharge Risk Score: Don't Go Home without It by O'Connor, C.M., Hasselblad, V., Tasissa, G., Pauly, D.F., Russell, S.D., Nohria, A., Koelling, T.M., Binanay, C., Shah, M.R., Sopko, G., Califf, R.M., Stevenson, L.W.

Get full text

The benefits of ribose in cardiovascular disease by Pauly, D.F., Johnson, C., St.Cyr, J.A.

“…Cardiovascular disease still ranks as the leading cause of death in men and women. Adults have tried to lower their risk of cardiovascular disease by improving…”
Get full text

Mitochondrial adenosine triphosphatase in the oxyphil cells of a renal oncocytoma by Hunter, V R, Pauly, D F, Wolkowicz, P E, McMillin, J B, Beckner, M E

“…Oxyphil cells are characterized by cytoplasm packed with large numbers of mitochondria. Study of these unusual cells may provide information about the…”
Get more information